Company news
Bgm Group Ltd. (NASDAQ:BGM) news
Bgm Group Ltd. news releases on 6ix. Latest, Feb 26, 2026: BGM Group Ltd. Receives NASDAQ Notice Related to Late Filing of Form 20-F
Press releases & updates
BGM Group Ltd. Receives NASDAQ Notice Related to Late Filing of Form 20-F
February 26, 2026
BGM To Report First Half 2025 Unaudited Financial Results on July 24, 2025
July 22, 2025
From Virtual Agents to Embodied and Industry-Specific AI: BGM Acquires Xingdao Intelligent and YD Network, Advancing AI on Two Fronts
May 28, 2025
BGM Group Announces Strategic Acquisition of HM Management to Expand AI Application Ecosystem
May 1, 2025
BGM Completes Acquisition of YX to Advance AI-Powered Intelligent Platform
April 28, 2025
BGM Group Acquires Wonder Dragon to Accelerate "Healthcare" Strategy
April 20, 2025
BGM Acquires YX to Strengthen AI Strategy for Its Intelligent Platform
March 18, 2025
BGM Group Announces Board Reshuffle: New Leadership Embarks on a Transformative Journey Amid Tech Revolution
February 27, 2025
BGM Group Establishes "Duxiaobao Management Committee" to Accelerate AI Strategy and Drive Intelligent Transformation in the Insurance Industry
February 18, 2025
BMG Completed Acquisition of High-Quality Assets, Marking a New Chapter in Diversified Growth
December 26, 2024
BGM Group and Jointown Deepen Cooperation, Ushering in a New Era of Pharmaceutical Development
December 18, 2024
/C O R R E C T I O N -- BGM Group Ltd/
November 28, 2024
BGM : SHARE SUBSCRIPTION AGREEMENT Form 6 K
November 27, 2024
BGM Group Welcomes Guilin Pharma for On-site Audit and Partnership Development
November 21, 2024
Qilian International Holding Group Limited Announces Name Change to BGM Group Ltd.
October 28, 2024
Qilian International plans to adjust industrial investment
May 16, 2024
Qilian International Holding Group Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule
January 11, 2024
Qilian International Holding Group Ltd Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
July 16, 2023
Qilian Received a Letter from Nasdaq Related to Regain Compliance
April 25, 2023
Qilian Received Notification of Deficiency from Nasdaq Related to not timely Filing of Annual Report Form 20-F
February 22, 2023
Qilian International Holding Group Ltd Declares Special Cash Dividends to Shareholders
February 15, 2023
Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2022
September 29, 2022
Qilian International Holding Group Limited Reports Fiscal Year 2021 Financial Results
February 10, 2022
Qilian International Holding Group Limited Receives Approval for the Sale of its Newly Developed Nitrofurantoin Enteric-coated Tablets
January 18, 2022
Qilian International Holding Group Limited Releases 2022 Chairman Letter
January 10, 2022
Qilian International Holding Group Limited Announces Inclusion of Gan Di Xin® and Qilian Shan® Oxytetracycline into List for Development of Leading Enterprises with Large Varieties and Brands of Pharmaceuticals of Gansu Province
November 22, 2021
Qilian International Holding Group Limited Announces Initiation of Development of New Drug for Gastric Cancer Prevention
November 14, 2021
Qilian International Holding Group Limited Donates Pharmaceutical Products Gan Di Xin® Worth RMB500,000 and Other Materials to Help Fight Local COVID-19 Epidemic
October 31, 2021
Qilian International Holding Group Limited Completes Phase One of Its Expansion of New Organic Fertilizer Production Facility and Puts It into Production
October 25, 2021
Qilian International Holding Group Limited Received Approval for Oxytetracycline API Export to Egypt
October 12, 2021
Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2021
September 15, 2021
Qilian International Holding Group Limited Enters into Investment Agreement for Pig By-product Processing Project in Chongqing
July 8, 2021
Qilian International Holding Group Limited Enters into Exclusive Agency Agreement with Kangzhiyuan to Boost Sales of Gan Di Xin®
May 4, 2021
Qilian International Holding Group Limited Announces Inclusion of 16 Products into China's National Reimbursement Drugs List
April 12, 2021
ATIF Holdings Limited Establishes Special Purpose Acquisition Company Department To Plan Establishment of SPAC To Fundraise Via IPO To Acquire Company With High Growth Potential
February 21, 2021
Qilian International Holding Group Limited CEO Receives Outstanding Entrepreneur Award
February 17, 2021
Qilian International Holding Group Limited Reports Fiscal Year 2020 Financial Results
February 10, 2021
Qilian International Holding Group Limited to Triple Organic Fertilizer Production Capacity by March 2021
February 7, 2021
Qilian International Holding Group Limited Announces Full Exercise of Underwriters’ Over-Allotment Option
January 18, 2021
Qilian International Holding Group Limited Announces Closing of Initial Public Offering
January 13, 2021
Qilian International Holding Group Limited Announces Pricing of Initial Public Offering
January 10, 2021